PROSTATE CARCINOMA METASTATIC IN THE BONE
Clinical trials for PROSTATE CARCINOMA METASTATIC IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CARCINOMA METASTATIC IN THE BONE trials appear
Sign up with your email to follow new studies for PROSTATE CARCINOMA METASTATIC IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for aggressive bladder and prostate cancers
Disease control OngoingThis early-stage trial is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy works better for treating advanced small cell or neuroendocrine cancers of the bladder, urethra, or prostate. The study will enroll about 15 participants with cancer tha…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Heat-and-Zap combo fights spine tumors
Disease control OngoingThis study is testing whether using two treatments together works better than one to control cancer that has spread to the spine and is at risk of pressing on the spinal cord. Doctors combine a heat treatment (thermal ablation) that destroys tumor cells with a very precise, high-…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Double attack on prostate cancer: testing a drug combo for tough cases
Disease control OngoingThis study is for men with advanced prostate cancer that has stopped responding to standard hormone therapy and has spread to the bones. It aims to see if adding a targeted radiation drug (Radium223) to a standard cancer-fighting pill (enzalutamide) works better than the pill alo…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug combo tested to control aggressive prostate cancer spread
Disease control OngoingThis study is testing whether a combination of three drugs can help control prostate cancer that has spread to other parts of the body. Researchers want to see if they can predict which patients will respond best to this treatment by analyzing tumor characteristics. The trial inv…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New immune therapy cocktail tested in fight against advanced cancers
Disease control OngoingThis study is testing the safety and effectiveness of avelumab, an immunotherapy drug, when given in combination with other immune-boosting drugs and sometimes radiation. It is for patients with advanced solid tumors that have spread and who have run out of standard treatment opt…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New combo attack on tough prostate cancer
Disease control OngoingThis study is for men whose prostate cancer has spread and stopped responding to standard hormone therapy and an initial round of chemotherapy. It tests if adding a second chemotherapy drug (cabazitaxel) to a standard hormone-blocking drug (abiraterone) is more effective at contr…
Matched conditions: PROSTATE CARCINOMA METASTATIC IN THE BONE
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC